This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1M Muscaritoli , SD Anker , J Argiles , et al. (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 29, 154–159.
2E Van Cutsem & J Arends (2005) The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs 9, S51–S63.
3MP Davis & D Dickerson (2000) Cachexia and anorexia: cancer's covert killer. Support Care Cancer 8, 180–187.
4K Fearon , F Strasser , SD Anker , et al. (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12, 489–495.
5WJ Evans , JE Morley , J Argiles , et al. (2008) Cachexia: a new definition. Clin Nutr 27, 793–799.
6F Bozzetti & L Mariani (2009) Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group. JPEN J Parenter Enteral Nutr 33, 361–367.
7KM Fox , JM Brooks , SR Gandra , et al. (2009) Estimation of cachexia among cancer patients based on four definitions. J Oncol .
8JM Argiles , FJ Lopez-Soriano , M Toledo , et al. (2011) The cachexia score (CASCO): a new tool for staging cachectic cancer patients. J Cachex Sarcopenia Muscle 2, 87–93.
9PJ Ross , S Ashley , A Norton , et al. (2004) Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer 90, 1905–1911.
10WD Dewys , C Begg , PT Lavin , et al. (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69, 491–497.
11A Laviano & MM Meguid (1996) Nutritional issues in cancer management. Nutrition 12, 358–371.
12JP Simons , AM Schols , WA Buurman , et al. (1999) Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci (Lond) 97, 215–223.
14L Ovesen , J Hannibal & EL Mortensen (1993) The interrelationship of weight loss, dietary intake, and quality of life in ambulatory patients with cancer of the lung, breast, and ovary. Nutr Cancer 19, 159–167.
16F Martin , F Santolaria , N Batista , et al. (1999) Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer. Cytokine 11, 80–86.
17BS Meij van der , JAE Langius , EF Smit , et al. (2010) Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment. J Nutr 140, 1774–1780.
20UG Kyle , L Genton , L Karsegard , et al. (2001) Single prediction equation for bioelectrical impedance analysis in adults aged 20–94 years. Nutrition 17, 248–253.
21D Gupta , CA Lammersfeld , PG Vashi , et al. (2009) Bioelectrical impedance phase angle in clinical practice: implications for prognosis in stage IIIB and IV non-small cell lung cancer. BMC Cancer 9, 37.
22JB Weir (1949) New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 109, 1–9.
24AW Moses , C Slater , T Preston , et al. (2004) Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 90, 996–1002.
28F Dati , AM Johnson & JT Whicher (2001) The existing interim consensus reference ranges and the future approach. Clin Chem Lab Med 39, 1134–1136.
29RW Bohannon , A Peolsson , N Massy-Westropp , et al. (2006) Reference values for adult grip strength measured with a Jamar dynamometer: a descriptive meta-analysis. Physiotherapy 92, 11–15.
32SM Slootmaker , MJ Chinapaw , AJ Schuit , et al. (2005) Promoting physical activity using an activity monitor and a tailored web-based advice: design of a randomized controlled trial [ISRCTN93896459]. BMC Public Health 5, 134.
33SM Slootmaker , MJ Chinapaw , AJ Schuit , et al. (2009) Concurrent validity of the PAM accelerometer relative to the MTI Actigraph using oxygen consumption as a reference. Scand J Med Sci Sports 19, 36–43.
36HJ Andreyev , AR Norman , J Oates , et al. (1998) Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34, 503–509.
37DC McMillan , JE Crozier , K Canna , et al. (2007) Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis 22, 881–886.
38X Jiang , N Hiki , S Nunobe , et al. (2012) Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer. Br J Cancer 107, 275–279.
40WJ Aronson , N Kobayashi , RJ Barnard , et al. (2011) Phase II prospective randomized trial of a low-fat diet with fish oil supplementation in men undergoing radical prostatectomy. Cancer Prev Res (Phila) 4, 2062–2071.
42CM Op den Kamp , RC Langen , R Minnaard , et al. (2012) Pre-cachexia in patients with stages I–III non-small cell lung cancer: Systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system. Lung Cancer 76, 112–117.
44AJ Staal-van den Brekel , AM Schols , MA Dentener , et al. (1997) The effects of treatment with chemotherapy on energy metabolism and inflammatory mediators in small-cell lung carcinoma. Br J Cancer 76, 1630–1635.
45Z Giannousi , I Gioulbasanis , AG Pallis , et al. (2012) Nutritional status, acute phase response and depression in metastatic lung cancer patients: correlations and association prognosis. Support Care Cancer 20, 1823–1829.
46I Gioulbasanis , P Georgoulias , PJ Vlachostergios , et al. (2011) Mini Nutritional Assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: interrelations and associations with prognosis. Lung Cancer 74, 516–520.
47EJ Coups , BJ Park , MB Feinstein , et al. (2009) Physical activity among lung cancer survivors: changes across the cancer trajectory and associations with quality of life. Cancer Epidemiol Biomarkers Prev 18, 664–672.
48E Gibney , M Elia , SA Jebb , et al. (1997) Total energy expenditure in patients with small-cell lung cancer: results of a validated study using the bicarbonate-urea method. Metabolism 46, 1412–1417.
49MJ Tisdale (2008) Catabolic mediators of cancer cachexia. Curr Opin Support Palliat Care 2, 256–261.